Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL A SCHWARTZ

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1972591683
CMS profile
43751
Location
MIAMI BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$6,704.43

304 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $6,664.21 301
Education $40.22 3

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $555.19 26
AstraZeneca Pharmaceuticals LP $439.30 19
Celgene Corporation $431.13 18
PFIZER INC. $417.48 23
Janssen Biotech, Inc. $399.99 16
ABBVIE INC. $286.87 12
Incyte Corporation $285.94 13
Gilead Sciences, Inc. $277.34 12
Takeda Pharmaceuticals U.S.A., Inc. $234.81 11
Daiichi Sankyo Inc. $234.49 12
GlaxoSmithKline, LLC. $228.58 9
Sumitomo Pharma America, Inc. $200.74 9
GENZYME CORPORATION $178.08 7
BeOne Medicines USA, Inc. $163.02 7
Merck Sharp & Dohme LLC $158.15 7
E.R. Squibb & Sons, L.L.C. $141.29 9
Tempus AI, Inc $139.70 7
Pharmacosmos Therapeutics Inc. $107.22 5
Stemline Therapeutics Inc. $104.16 6
Bayer Healthcare Pharmaceuticals Inc. $97.29 4
Deciphera Pharmaceuticals Inc. $94.57 4
INTUITIVE SURGICAL, INC. $93.69 1
Astellas Pharma US Inc $90.73 4
SOBI, INC $89.16 4
BeiGene USA, Inc. $80.69 3
SERVIER PHARMACEUTICALS LLC $79.43 3
Adaptive Biotechnologies Corporation $78.44 4
ARRAY BIOPHARMA INC $69.17 3
Eisai Inc. $68.14 3
Rigel Pharmaceuticals, Inc. $62.61 3
Genentech USA, Inc. $62.13 3
Lilly USA, LLC $56.10 3
Ipsen Biopharmaceuticals, Inc $53.23 2
Exelixis Inc. $50.04 2
Regeneron Healthcare Solutions, Inc. $49.69 2
SpringWorks Therapeutics, Inc. $44.67 2
TerSera Therapeutics LLC $44.56 2
Agios Pharmaceuticals, Inc. $43.67 2
Legend Biotech USA Inc. $35.18 2
Aveo Pharmaceuticals, Inc. $28.00 1
Janssen Pharmaceuticals, Inc $24.23 2
GE HEALTHCARE $24.14 1
TAIHO ONCOLOGY, INC. $23.93 1
Blueprint Medicines Corporation $23.75 1
EMD Serono, Inc. $23.49 1
Syndax Pharmaceuticals, Inc. $22.98 1
Boehringer Ingelheim Pharmaceuticals, Inc. $22.73 1
pharmaand GmbH $21.83 2
Iovance Biotherapeutics, Inc. $20.86 1
Genmab U.S., Inc. $20.64 1
PUMA BIOTECHNOLOGY, INC. $20.40 1
Invivyd Inc $19.33 1
JAZZ PHARMACEUTICALS INC. $18.40 1
Karyopharm Therapeutics Inc. $17.48 1
Abbott Laboratories $16.49 1
Geron Corporation $14.82 1
TOLMAR, INC. $14.26 1

Page 2 of 7; records 51–100 of 304 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL A SCHWARTZ

NPI 1972591683 · CMS profile ID 43751

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

MIAMI BEACH, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 7; records 51–100 of 304 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972591683?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL A SCHWARTZ, NPI 1972591683, CMS profile ID 43751. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 304 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972591683?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). MICHAEL A SCHWARTZ, NPI 1972591683, CMS profile ID 43751. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 7; records 51–100 of 304 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972591683?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
MICHAEL A SCHWARTZ, NPI 1972591683, CMS profile ID 43751, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 7; records 51–100 of 304 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1972591683?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

304 matching records · $6,704.43 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 304 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 304.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
pharmaand GmbH $7.5710/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1182990362 CMS
Regeneron Healthcare Solutions, Inc. $21.7810/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1213035829 CMS
Novartis Pharmaceuticals Corporation $23.1910/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200436828 CMS
Stemline Therapeutics Inc. $14.8810/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244099626 CMS
GENZYME CORPORATION $16.8410/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233247274 CMS
PFIZER INC. $15.3810/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229865768 CMS
BeOne Medicines USA, Inc. $29.3910/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202911781 CMS
Merck Sharp & Dohme LLC $27.9010/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238078207 CMS
Gilead Sciences, Inc. $27.6010/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234454253 CMS
Janssen Biotech, Inc. $34.8510/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175163019 CMS
Novartis Pharmaceuticals Corporation $45.9810/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200436832 CMS
Sumitomo Pharma America, Inc. $24.0710/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1176717563 CMS
Adaptive Biotechnologies Corporation $21.6910/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254935804 CMS
Gilead Sciences, Inc. $26.0610/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234465589 CMS
ABBVIE INC. $21.5510/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1204136946 CMS
Janssen Biotech, Inc. $17.5010/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175163374 CMS
Lilly USA, LLC $21.1610/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186812705 CMS
Celgene Corporation $32.7410/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184838121 CMS
Gilead Sciences, Inc. $24.0110/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234484256 CMS
Daiichi Sankyo Inc. $15.4010/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197033543 CMS
Daiichi Sankyo Inc. $14.4510/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197035665 CMS
GE HEALTHCARE $24.1410/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244283316 CMS
GENZYME CORPORATION $32.8810/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233247272 CMS
AstraZeneca Pharmaceuticals LP $26.9710/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206406756 CMS
Iovance Biotherapeutics, Inc. $20.8610/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251399496 CMS
SOBI, INC $27.8110/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240287969 CMS
Takeda Pharmaceuticals U.S.A., Inc. $20.0809/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223858053 CMS
BeOne Medicines USA, Inc. $19.0909/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202911787 CMS
Aveo Pharmaceuticals, Inc. $28.0009/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199897260 CMS
Bayer Healthcare Pharmaceuticals Inc. $28.9009/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225778441 CMS
Janssen Biotech, Inc. $26.4009/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175160954 CMS
Incyte Corporation $25.8009/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226183709 CMS
Pharmacosmos Therapeutics Inc. $23.9309/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250730676 CMS
AstraZeneca Pharmaceuticals LP $28.7909/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207062978 CMS
PUMA BIOTECHNOLOGY, INC. $20.4009/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251750494 CMS
TOLMAR, INC. $14.2609/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237025824 CMS
pharmaand GmbH $14.2609/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1182989792 CMS
Janssen Biotech, Inc. $31.8509/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175160976 CMS
Merck Sharp & Dohme LLC $21.6909/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238123593 CMS
PFIZER INC. $17.2309/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229108795 CMS
Ipsen Biopharmaceuticals, Inc $29.3909/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208825983 CMS
Novartis Pharmaceuticals Corporation $25.2209/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572993 CMS
AstraZeneca Pharmaceuticals LP $16.6309/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206682505 CMS
AstraZeneca Pharmaceuticals LP $23.9909/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206884349 CMS
Celgene Corporation $17.4009/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184838115 CMS
Daiichi Sankyo Inc. $28.5609/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197027267 CMS
Stemline Therapeutics Inc. $17.8809/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244099622 CMS
Incyte Corporation $23.0509/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226142163 CMS
Novartis Pharmaceuticals Corporation $20.7509/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200572991 CMS
Exelixis Inc. $25.0409/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218799163 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $4,452.03 274
PY2020 $3,347.04 189
PY2021 $3,430.52 185
PY2022 $3,267.13 165
PY2023 $4,408.28 224
PY2024 $5,215.77 257
PY2025 $6,704.43 304

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $18,127.00 10
PY2024 Principal investigator $9,716.00 10
PY2023 Principal investigator $38,421.00 12
PY2022 Principal investigator $2,800.00 5
PY2021 Principal investigator $3,675.70 6
PY2020 Principal investigator $1,908.66 14
PY2019 Principal investigator $3,925.00 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $1,552.00 12/01/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
Single agent GDC 9545 vs endocrine monotherapy adjuvant treatment in HR eBC No dispute reported 06/30/2026 1211550898
Principal investigator 1 PFIZER INC. $500.00 10/17/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE FOR HR OR HER2 EARLY BREAST CANCER WI203696 No dispute reported 06/30/2026 1228708834
Principal investigator 1 Genentech, Inc. $904.00 10/09/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
Single agent GDC 9545 vs endocrine monotherapy adjuvant treatment in HR eBC No dispute reported 06/30/2026 1211550902
Principal investigator 1 Genentech, Inc. $1,044.00 09/25/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
Single agent GDC 9545 vs endocrine monotherapy adjuvant treatment in HR eBC No dispute reported 06/30/2026 1211550848
Principal investigator 1 Genentech, Inc. $1,583.00 05/06/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
Single agent GDC 9545 vs endocrine monotherapy adjuvant treatment in HR eBC No dispute reported 06/30/2026 1211550844
Principal investigator 1 PFIZER INC. $500.00 04/29/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE FOR HR OR HER2 EARLY BREAST CANCER WI203696 No dispute reported 06/30/2026 1228708836
Principal investigator 1 PFIZER INC. $500.00 04/02/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE FOR HR OR HER2 EARLY BREAST CANCER WI203696 No dispute reported 06/30/2026 1228709008
Principal investigator 1 PFIZER INC. $500.00 03/12/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
PALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRINE THERAPY VERSUS STANDARD ADJUVANT ENDOCRINE THERAPY ALONE FOR HR OR HER2 EARLY BREAST CANCER WI203696 No dispute reported 06/30/2026 1228708838
Principal investigator 1 PFIZER INC. $10,000.00 02/03/2025 Non-covered Recipient Entity
Mount Sinai Medical Center of Florida Inc
THE COMPASSHER2 TRIALS COMPREHENSIVE USE OF PATHOLOGIC RESPONSE ASSESSMENT TO OPTIMIZE THERAPY IN HER2POSITIVE BREAST CANCER COMPASSHER2 RESIDUAL DISEASE RD A DOUBLEBLINDED PHASE III RANDOMIZED TRIAL OF TDM1 COMPARED WITH TDM1 AND TUCATINIB No dispute reported 06/30/2026 1228782810
Principal investigator 1 Genentech, Inc. $1,044.00 01/30/2025 Covered Recipient Teaching Hospital
Mount Sinai Medical Center Of Florid
Single agent GDC 9545 vs endocrine monotherapy adjuvant treatment in HR eBC No dispute reported 06/30/2026 1211550754